Clinical Study

Otsuka Tolvaptan Open Label Rollover Study For Adpkd

Posted Date: Oct 7, 2016

  • Investigator: Shashi Kant
  • Co-Investigator: Karen Case
  • Specialties: Kidney Disease, Nephrology
  • Type of Study: Drug

Tolvaptan is being studied as a possible treatment for autosomal dominant polycystic kidney disease (ADPKD). ADPKD is a disease that causes kidney cysts (cysts are like fluid-filled balloons), worsening kidney function, blood in the urine, kidney pain, hi

Criteria:

Inclusion: Previous Participation In Otsuka 156-13-210 Double Blind Study, Egfr >= 20 Exclusion: Hepatic Impairment, Breast-Feeding Or Pregnant, Need For Chronic Diuretics

Keywords:

Kidney Disease, Adpkd, Cysts, Nephrology, Null

For More Information:

Karen Case, Ccrp
513-559-3367
karen.case@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.